MULTIPLE HATS: STEM Careers | Reinvention | Entrepreneurship |Thought Leadership

Why Great MedTech Fails, and What It Really Takes to Build a Company That Works with Ben Wright, co-foudner of Mimetic Foundry

MULTIPLE HATS: STEM Careers | Reinvention | Entrepreneurship |Thought Leadership

Show Notes

Why do some of the most brilliant medical technologies never reach patients, even when the science works?

🔍 What You’ll Learn: If you’ve ever thought “build a great technology and the rest will follow,” this episode will challenge that fast. Because in healthcare, the system decides what survives, not just the science. This conversation breaks down what actually makes or kills a MedTech company, and what you need to understand if you want to move from technical expertise to real-world impact. Why clinical workflow, incentives, and reimbursement matter more than your innovation The “value triangle” every MedTech product must satisfy to survive How to stop trying to be everything in a startup, and build the right team early This is where a STEM career shifts from “doing the work” to understanding how the system works, and how to influence it.

If you want to think like a strategist, not just a scientist, play this episode and start seeing where great ideas actually fail.

🧠 About the Guest: Ben Wright is a MedTech investor, advisor, and co-founder of Mimetic MedTech Foundry. He started in biological sciences and hand transplant research, then moved into the business side after seeing firsthand that great technology alone doesn’t guarantee success. Today, he works at the intersection of science, clinical practice, and business, helping turn early-stage ideas into viable companies by building the right structure around them.

📌 Episode Highlights: 00:00 Why great medical technologies fail despite strong science 03:00 From researcher to startup builder, the first reality check 06:30 Why accelerators don’t prepare founders for real MedTech timelines 10:00 Should scientific founders be CEOs? 14:00 The “value triangle”: clinical outcome, convenience, cost 18:00 The oral chemotherapy example, when incentives block better care 21:00 Why human behavior and workflow kill adoption 24:00 When better tech loses to incumbent business models 28:00 True disruption, and why it’s harder than you think 33:00 Why Australia struggles to fund MedTech innovation 38:00 What a venture studio actually does differently 46:00 A real MedTech failure story, and what it teaches about risk

🔗 Resources Mentioned: 🎧 Quick Fire Chat with Ben Wright https://shows.acast.com/multiple-hats/episodes/69ad4b747036d73902764808 Mimetic MedTech Foundry

🤔 Reflection Time: Where are you focusing only on the “technology” in your work, and ignoring the system it needs to fit into? If you stepped back, what part of your work is actually about influence, not execution? What would change if you stopped trying to do everything yourself and built around your strengths instead?

This episode is a reality check. Not to discourage you, but to show you where the real leverage is.

Want to craft a career story that opens doors? I help STEMM professionals speak with clarity, confidence, and purpose and show up as thought leaders —so the right opportunities find you. 📬 Let’s connect: angeliquegreco.com.au | LinkedIn

⭐️ Help More People Reinvent Their Careers If you enjoyed this episode, please: ✅ Leave a quick ⭐️⭐️⭐️⭐️⭐️ review on Apple Podcasts or Spotify 🙏 ♻️ Share it with a friend who's questioning their path in STEM Hosted on Acast. See acast.com/privacy for more information.

More from MULTIPLE HATS: STEM Careers | Reinvention | Entrepreneurship |Thought Leadership

Oct 12, 2026

You have promising science. But is there actually a commercial opportunity behind it? And if you’re considering moving from scientist to entrepreneur, how do you know whether your research has the ingredients for a biotech company?

Sep 28, 2026

What happens when scientists stop presenting their research to other scientists and put it in front of biotech and drug development experts instead? The questions change. Suddenly it isn’t only, “Does the science work?” It’s also: Who is the patient? What is the indication? What evidence do you need next? What could stop this programme? Who needs to partner with you? And what would a credible path to the clinic actually look like?

Sep 14, 2026

Should your research become a medicine? And if it has commercial potential, should you be the scientist who takes it forward? For academics considering the move from scientist to entrepreneur, that decision starts well before forming a biotech company.

Aug 24, 2026

A rapid-fire conversation on transferable STEM skills, working smarter, visibility and what is actually good enough to start.

Aug 17, 2026

How a nurse turned a recurring healthcare problem into NeedleCalm, and what ten years of building taught her about medtech entrepreneurship.

See all episodes →